Legal group sues FDA over puberty blocker records, citing Biden-era cover-up

America First Legal AFL sued the Food and Drug Administration on Friday to obtain Biden-era records related to the government's internal guidance surrounding the recommended use of puberty blockers for kids The Trump-aligned legal group previously uncovered communications from the former administration through a Freedom of Information Act FOIA request which reportedly revealed the FDA knew that these drugs increased mental wellness menace but still recommended approving them for kids Following those uncovered communications AFL followed up with a separate FOIA requesting documents specifically pertaining to the FDA's internal guidance around the off-label use of these drugs However despite acknowledging the federal information request the FDA has not cooperated and the deadline to produce documents is up DEMOCRATIC STATES SUE TRUMP ADMIN OVER ENDING SEX CHANGE SURGERIES FOR MINORS The Biden administration pushed gender-denying treatments on American kids Now it s time to expose what officers really knew AFL counsel Will Scolinos announced Similar to AFL's current FOIA request the group was required to engage in litigation to compel the release of the first set of documents But eventually documents were circulated that seemed to show the Biden-era Division of General Endocrinology at the FDA recommended the agency approve puberty blockers for children despite the knowledge that there were deleterious impacts associated with them such as increased depression suicidality and seizure risks There is definitely a need for these drugs to be approved for gender transition an FDA official from the agency's endocrinology division stated in an email uncovered by AFL In the same communications the FDA official also explicitly states that studies they conducted unveiled increased liability of depression and suicidality as well as increased seizure exposure Such findings have been verified by other studies as well Researchers at the University of Texas sampled patients aged and over who had gender dysphoria including a few who underwent gender-change surgery and concluded that gender-sensitive mental wellness encouragement to address post-surgical psychological risks is a necessity PROGRESSIVES TRAPPED IN 'MISINFORMATION BUBBLE' ABOUT TRANSGENDER YOUTH TREATMENTS ATLANTIC WRITER ADMITS Males who received surgery had depression rates of compared to males without surgery who had rates slightly below Anxiety rates among that group were compared to The same differences were seen among females as well Those with surgery had depression rates compared to in the non-surgical group Females who did get surgery also had a rate of anxiety of compared to for girls who had not gotten surgery Fox News Digital reached out to the FDA for comment but did not promptly receive a response